- Home
- TJX vs PFE Comparison
TJX vs PFE Comparison
Compare TJX & PFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TJX | PFE |
|---|---|---|
| Founded | 1962 | 1849 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 173.6B | 147.6B |
| IPO Year | 1994 | 2013 |
Fundamental Metrics
Financial Performance| Metric | TJX | PFE |
|---|---|---|
| Price | $164.29 | $25.22 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 14 |
| Target Price | ★ $169.00 | $29.29 |
| AVG Volume (30 Days) | 4.9M | ★ 25.0M |
| Earning Date | 05-20-2026 | 05-05-2026 |
| Dividend Yield | 1.23% | ★ 6.55% |
| EPS Growth | ★ 14.32 | N/A |
| EPS | ★ 1.19 | 0.47 |
| Revenue | $29,078,407,000.00 | ★ $62,579,000,000.00 |
| Revenue This Year | $6.75 | N/A |
| Revenue Next Year | $5.81 | N/A |
| P/E Ratio | $137.81 | ★ $55.29 |
| Revenue Growth | ★ 6.04 | N/A |
| 52 Week Low | $119.84 | $23.11 |
| 52 Week High | $170.00 | $28.75 |
Technical Indicators
Market Signals| Indicator | TJX | PFE |
|---|---|---|
| Relative Strength Index (RSI) | 57.99 | 38.94 |
| Support Level | $152.63 | $25.06 |
| Resistance Level | $165.82 | $26.41 |
| Average True Range (ATR) | 3.22 | 0.46 |
| MACD | 0.46 | 0.01 |
| Stochastic Oscillator | 65.80 | 18.39 |
Price Performance
Historical ComparisonAbout TJX TJX Companies Inc. (The)
Founded in 1987, TJX Companies is the world's largest off-price apparel and home fashions retailer, operating more than 5,000 stores across nine countries. In fiscal 2026, the company generated roughly $60 billion in sales. TJX operates through four segments: Marmaxx (61% of sales), HomeGoods (17%), TJX Canada (9%), and TJX international (13%). Its off-price model emphasizes branded merchandise at meaningful discounts, driving high traffic and rapid inventory turnover.
About PFE Pfizer Inc.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.